ÂÜÀòÂÒÂ×

Paul Seaback brings nearly 25 years of commercial and clinical pharmaceutical supply chain and manufacturing experience to Dermavant. Early in his career he held leadership roles at active pharmaceutical ingredient and drug product manufacturing sites before assuming roles developing and leading global supply chains. Prior to joining Dermavant in May 2018, Mr. Seaback was VP, Supply Chain and Sourcing Operations at IGNYTA until its acquisition by Roche. Mr. Seaback also led the global supply chain and manufacturing at Gilead Sciences and Medicis Pharmaceutical, and held positions of increasing responsibility with Hospira, Mayne Pharma and Novartis. Mr. Seaback has led the supply chain for several new product launches across multiple therapeutic areas and regions including SOVALDI, HARVONI, GENVOYA, ODEFSEY, DESCOVY, and VEMLIDY. Mr. Seaback earned his BS in business, economics, and marketing from Colorado State University.